Next-generation sequencing-guided molecular-targeted therapy and immunotherapy for biliary tract cancers-Reference-Cited by-同舟云学术

Next-generation sequencing-guided molecular-targeted therapy and immunotherapy for biliary tract cancers

Published:2020-10-23 Issue:4 Volume:70 Page:1001-1014
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Zhang Wei^ORCID,Shi Junping,Wang Yingying,Zhou Hongyuan,Zhang Zewu,Han Zhiqiang,Li Guanghao,Yang Bo,Cao Guangtai,Ke Yan,Zhang Ti,Song Tianqiang,QiangLi

Funder

National Natural Science Foundation of China

Ministry of Science and Technology, National Science and Technology Major Special Project

“Young Medical Elites,” Tianjin Health Commission

“Young Innovative Talents,” Tianjin Medical University Cancer Institute and Hospital

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-020-02745-y.pdf

Reference33 articles.

1. Tella SH, Kommalapati A, Borad MJ, Mahipal A (2020) Second-line therapies in advanced biliary tract cancers. Lancet Oncol 21(1):e29–e41. https://doi.org/10.1016/S1470-2045(19)30733-8

2. Rizvi S, Khan SA, Hallemeier CL, Kelley RK, Gores GJ (2018) Cholangiocarcinoma - evolving concepts and therapeutic strategies. Nat Rev Clin Oncol 15(2):95–111. https://doi.org/10.1038/nrclinonc.2017.157

3. Rizvi S, Gores GJ (2013) Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology 145(6):1215–1229. https://doi.org/10.1053/j.gastro.2013.10.013

4. Razumilava N, Gores GJ (2014) Cholangiocarcinoma. Lancet 383(9935):2168–2179. https://doi.org/10.1016/S0140-6736(13)61903-0

5. Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BJ, Youssef BM, Klimstra D, Blumgart LH (2001) Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234(4):507–517. https://doi.org/10.1097/00000658-200110000-00010

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Immunotherapy for Advanced Biliary Tract Cancer;Current Treatment Options in Oncology;2024-07-27

2. Evaluating the Therapeutic Potential of Durvalumab in Adults with Locally Advanced or Metastatic Biliary Tract Cancer: Evidence to Date;OncoTargets and Therapy;2024-05

3. Clinical activity of Mitogen-Activated Protein Kinase (MAPK) inhibitors in patients with MAP2K1 (MEK1)-mutated metastatic cancers;2024-03-24

4. Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing;Cancer Treatment Reviews;2024-01

5. Case report: Remarkable response to sintilimab, lenvatinib, and nab-paclitaxel in postoperative metastatic chemotherapy-resistant combined hepatocellular-cholangiocarcinoma;Frontiers in Pharmacology;2023-10-13